NEW YORK (360Dx) – Chembio Diagnostics reported after the close of the market on Thursday that its third quarter revenues rose 24 percent year over year. 

For the three months ended Sept. 30, Chembio reported revenues of $9.4 million compared to $7.6 million in the prior-year quarter.

Product sales rose 30 percent to $7.9 million from $6.1 million. R&D, milestone, and grant revenues were flat year over year at $1.3 million, and license and royalty revenues rose 52 percent to $228,553 from $150,000 a year earlier.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.